John J. Sperzel III

Insider Reports History

Location
Brunswick, ME
Signature
/s/ John Sprague, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John J. Sperzel III:

Form 4 holding Chairman, President & CEO, Director

T2 Biosystems, Inc.

Security class
Restricted Stock Units
Shares / value
490,000
Estimated value
$77,175
Report date
04 Nov 2024
Price
$0.1575
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chairman, President & CEO, Director

T2 Biosystems, Inc.

Security class
Common Stock
Shares / value
400
Estimated value
$63
Report date
24 Feb 2024
Price
$0.1575
Ownership
Direct

Insider Reports Filed by John J. Sperzel III

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .